Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT
|
|
- Emma Lane
- 5 years ago
- Views:
Transcription
1 Am J Physiol Endocrinol Metab 281: E966 E974, Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT ANDREA TURA, 1 BERNHARD LUDVIK, 2 JOHN J. NOLAN, 3 GIOVANNI PACINI, 1 AND KARL THOMASETH 1 1 Institute of Systems Science and Biomedical Engineering, Italian National Research Council, Padua, Italy; 2 Division of Endocrinology and Metabolism, Department of Medicine 3, University of Vienna Medical School, A-1090 Vienna, Austria; and 3 Department of Endocrinology, St. James s Hospital, Trinity College, Dublin 8, Ireland Received 29 November 2000; accepted in final form 14 June 2001 Tura, Andrea, Bernhard Ludvik, John J. Nolan, Giovanni Pacini, and Karl Thomaseth. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab 281: E966 E974, To directly evaluate prehepatic secretion of pancreatic hormones during a 3-h oral glucose tolerance test (OGTT), we measured insulin and C-peptide in six healthy control, six obese, and six type 2 diabetic subjects in the femoral artery and hepatic vein by means of the hepatic catheterization technique. Hypersecretion in obesity was confirmed ( nmol in obese vs in control and in diabetic subjects, P 0.01), whereas early phase secretion was impaired in diabetes. We also measured hepatic insulin extraction (higher in diabetic than in control subjects, P 0.03) and insulin clearance. The measured data were also used to validate a previously proposed mathematical model, developed to quantify prehepatic secretion, hepatic insulin extraction, and insulin clearance during OGTT, when C-peptide and insulin concentrations are systemically measured. We found good correspondence between experimental data and model estimates for prehepatic insulin secretion (P 0.3, r ), whereas estimation of hepatic insulin extraction and insulin clearance needs further investigation for improvement. oral glucose tolerance test; insulin clearance; pancreatic hormones; hepatic catheterization; mathematical modeling GLUCOSE HOMEOSTASIS in the postprandial state is regulated by the balanced interplay among the absorption of glucose from the gut, splanchnic glucose uptake, and secretion and effectiveness of pancreatic -cell hormones that regulate the uptake and production of glucose by target tissues (7). Knowledge of the secretion, kinetics, and clearance of pancreatic hormones and their possible interrelations during a physiological test is quite limited, because the direct assessment of portal levels of various hormones is not feasible in human subjects. On the other hand, measurements of peripheral levels do not always reflect the prehepatic concentration of the hormones and do not elucidate potential interactions of the liver on glucose metabolism. Thus one of the aims of this study was to directly evaluate endogenous secretion of C-peptide and insulin and their kinetics during an oral glucose tolerance test (OGTT). This is a physiological test involving the normal route of glucose intake. We applied the hepatic catheterization technique, which allows the direct assessment of the transsplanchnic balance of pancreatic hormones. A second aim was the validation, against the experimental data obtained from the hepatic catheterization technique, of a mathematical model (23) that yields quantitative information on prehepatic -cell secretion during the OGTT when C-peptide and insulin concentrations are systemically measured. Glossary BCS(t) C-peptide and insulin secretion rate (pmol/min) from measurements (Eqs. 2 5 and 7 8) Clearance C-Pep Systemic C-peptide clearance (l/ min) from measurements (Eq. 7) Clearance Ins Systemic insulin clearance (l/min) from measurements (Eq. 8) CP(t) C-peptide plasma concentration (pmol/l) predicted by the model (Eq. 9) CPa(t) C-peptide concentration (pmol/l) measured in the artery (Eqs. 2 and 7) CPv(t) C-peptide concentration (pmol/l) measured in the hepatic vein (Eq. 2) CPS(t) C-peptide and insulin secretion rate (pmol l 1 min 1 ) from model estimations (Eqs. 9 and 10) F Posthepatic insulin fractional appearance (dimensionless) from model estimations (Eq. 10) Address for reprint requests and other correspondence: K. Thomaseth, LADSEB-CNR, Corso Stati Uniti, 4, Padua, Italy ( Karl.Thomaseth@ladseb.pd.cnr.it). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. E /01 $5.00 Copyright 2001 the American Physiological Society
2 INSULIN AND C-PEPTIDE SECRETION AND KINETICS E967 METHODS Subjects HBF(t) Hepatic blood flow (l/min) (Eqs. 2 6) HCL(t) Hepatic insulin clearance (l/min) from measurements (Eq. 6) HE(t) Hepatic insulin degradation (pmol/ min) from measurements (Eqs. 3 and 4) HIFC(t) Hepatic insulin fractional extraction (dimensionless) from measurements (Eqs. 4 6 and 8) I(t) Insulin plasma concentration (pmol/l) predicted by the model (Eq. 10) Ia(t) Insulin concentration (pmol/l) measured in the artery (Eqs. 3 5 and 8) Iv(t) Insulin concentration (pmol/l) measured in the hepatic vein (Eqs. 3 and 5) k 01 Systemic C-peptide fractional clearance (min 1 ). It is a fixed parameter in model estimations (Eq. 9) n Systemic insulin fractional clearance (min 1 ) from model estimations (Eq. 10) Six male lean, nondiabetic [age yr, body mass index (BMI) kg/m 2 ], six male obese, nondiabetic ( yr, BMI kg/m 2 ), and six diabetic subjects (5 male, 1 female, yr, BMI kg/m 2, diabetes duration yr) participated in the study. All subjects were admitted 3 days before the respective study to the San Diego Veterans Affairs Medical Center s Special Diagnostic and Treatment Unit and consumed a weight maintenance diet containing 55% carbohydrate, 30% fat, and 15% protein. None of the nondiabetic subjects had a positive family history for diabetes or was taking any medication known to affect glucose metabolism. The purpose, nature, and potential risks of the study were explained in detail to all subjects before their written consent was obtained. The study protocol was reviewed and approved by the Human Subjects Committee of the University of California San Diego. All studies were performed at 8.00 AM after a 10- to 12-h overnight fast. Experimental Procedure Under local anesthesia with 2% lidocaine, the femoral artery was punctured with an 18-gauge needle, and a 5-French Teflon catheter was introduced and positioned fluoroscopically at the level of the inferior end of the sacroiliac joint. The femoral vein was similarly punctured, and a 6.5- French polyethylene catheter was advanced under fluoroscopic control via the inferior vena cava into the right-sided hepatic vein in an area of adequate blood flow. Hepatic blood flow was estimated by a primed continuous infusion of indocyanine green (19). The dye infusion was started via an antecubital vein 75 min before glucose ingestion and continued throughout the study. Blood was sampled simultaneously from the artery and the hepatic vein at 10- min intervals starting 45 min after the beginning of green Fig. 1. Schematic representation of the physiological system under study. This model is used for calculating pancreatic secretion and extraction by the liver of insulin. The star denotes where the direct measurements are obtained. dye infusion. At time 0, the subjects ingested 300 ml of a 75-g glucose solution over 5 min. Arterial and hepatic venous blood was sampled at 15-min intervals to determine the concentrations of glucose, C-peptide, insulin, and indocyanine green for 3 h after glucose ingestion. Hepatic plasma flow was calculated by dividing the green dye infusion rate by arteriohepatic venous dye concentration difference. Hepatic blood flow was estimated by dividing hepatic plasma flow by (1 hematocrit). Glucose was measured with a YSI automated glucose analyzer (Yellow Springs Instrument, Yellow Springs, OH) and C-peptide as described in Ref. 5. Insulin was assayed by double-antibody radioimmunoassay (4). Indocyanine green was analyzed by spectrophotometer after precipitation with sodium deoxycholate (8). The measurement errors, expressed as interassay coefficient of variation, were 1.5% for glucose, 5% for insulin, and 10% for C-peptide. Direct-Measurement Data Analysis Whole body kinetics were described with a circulatory model that includes the main processes involving the liver. In particular, this organ is represented as a compartment with inputs from the portal vein (pancreatic secretion) and the hepatic artery, and output in the hepatic vein. As a process of substrate disappearance from the liver, degradation in the hepatocytes is considered (Fig. 1). As the overall system can be assumed to be in a quasisteady state, given the slow dynamics of the OGTT, the mass flux of peptide across the liver was described as the steady-state equation outflow inflow secretion extraction (1) which can be applied to both C-peptide and insulin. For C-peptide, it is known that only a negligible proportion is degraded in the liver (20); therefore, Eq. 1 becomes CPv t HBF t CPa t HBF t BCS t (2) where CPv(t) and CPa(t) are C-peptide concentrations (pmol/l) in the hepatic vein and in the artery, respectively, HBF(t) is the measured hepatic blood flow (l/min), and BCS(t) is -cell C-peptide secretion rate (pmol/min). The only unknown is BCS(t), which can thus be calculated. Given the equimolar release of C-peptide and insulin, BCS(t) also represents -cell insulin secretion. The integral between 0 and 180 min of BCS(t) gives the total amount of insulin secretion (nmol). The ratio of total amount of insulin secretion to area under the curve (AUC) of glucose concentration provides an index of -cell sensitivity to glucose stimulation. Equation 1 applied to insulin is Iv t HBF t Ia t HBF t BCS t HE t (3) where Iv(t) and Ia(t) are insulin concentrations (pmol/l) in the hepatic vein and in the artery, respectively, and HE(t) is the
3 E968 INSULIN AND C-PEPTIDE SECRETION AND KINETICS hepatic insulin degradation (pmol/min) and is expressed as a fraction of the amount of the hormone entering the liver, i.e. HE t HIFC t Ia t HBF t BCS t (4) where HIFC(t) is the hepatic insulin fractional extraction (dimensionless), calculated by substituting Eq. 4 in Eq. 3 HIFC t 1 Iv t HBF t / Ia t HBF t BCS t (5) Hepatic insulin clearance HCL(t) (l/min) can be computed as HCL t HIFC t HBF t (6) Systemic C-peptide clearance (l/min) was calculated as the ratio of the time integral of secretion rate to that of C-peptide concentration in the artery (which is equal to mixed venous blood concentration) clearance C-Pep BCS t dt 180 CPa t dt Similarly, systemic insulin clearance (l/min), which does not include first-pass hepatic degradation, was calculated as the ratio of the time integral of secretion rate multiplied by hepatic insulin fractional delivery, 1 HIFC(t), to that of arterial insulin concentration clearance Ins 0 Model-Based Data Analysis HIFC t BCS t dt Ia t dt The aforementioned circulatory model was used for analyzing experimental data. Here, we briefly recall the model of insulin secretion and kinetics from OGTT that we want to validate against the measurements directly obtained with the hepatic catheterization protocol. A detailed description of the model with all the assumptions and hypotheses has been reported in Ref. 23. For C-peptide, the following mathematical description was adopted (7) (8) dcp t /dt k 01 CP t CPS t (9) where CP(t) is the measured plasma C-peptide concentration (pmol/l), k 01 is the disappearance constant, which represents the systemic C-peptide fractional clearance (min 1 ), and CPS(t) is the C-peptide secretion rate estimated by the model (pmol l 1 min 1 ); it also represents insulin secretion, since C-peptide is released equimolarly with insulin. The initial condition is provided by the basal C-peptide level, measured immediately before the glucose load. A considerable amount of insulin is extracted by the liver, and only a fraction F of CPS(t) constitutes the posthepatic appearance of the hormone in the peripheral circulation. Insulin kinetics are described by di t /dt ni t F CPS t (10) where I(t) is the measured plasma insulin concentration (pmol/l), n is the systemic insulin fractional clearance (min 1 ), and F CPS(t) is the posthepatic insulin delivery; (1 F) represents the hepatic insulin fractional extraction (dimensionless). The initial condition is given by the basal insulin value. In this study, CP(t) and I(t) were fitted to CPa(t) and Ia(t) from the hepatic catheterization experiment, respectively. Equations 9 and 10 represent a monocompartmental description for C-peptide and insulin kinetics, which is an approach already adopted in other kinetic models (1, 2, 26). Individualized time courses of C-peptide and insulin secretion rate CPS(t) were estimated by use of the approach proposed previously (23), which is based on a parametric mathematical representation of CPS(t) in terms of continuous piecewise polynomials (splines). These are made up of a series of quadratic polynomials that are joined at specific knot points (3), i.e., 0, 0, 15, 30, 60, 90, 120, 150, 180, 180, and 180. This sequence is slightly different from that used in Ref. 23 to maintain close resemblance to the sampling schedule of the hepatic catheterization experiments, i.e., 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min. Double knots at t 0 were introduced to enable the description of a rapid increase of insulin secretion at the beginning of the experiment; triple knots at t 180 min were used to describe the sustained insulin release at the end of the observation interval (23). Nonlinear weighted least squares were used for estimating the unknown parameters in the spline representation of the C-peptide and insulin secretion rate CPS(t) and the fraction F characterizing insulin appearance. The adopted weights were the inverse of the variance of the measurement errors. Total amount of insulin secretion (nmol/l) was estimated by integrating CPS(t) over 180 min. In the original model (23), insulin fractional clearance n was a fixed parameter assumed equal to that calculated from other studies and not estimated. Here, n was estimated as a model parameter to increase the possibility of using the method in subjects who can exhibit variations at the level of systemic insulin clearance. The C-peptide fractional clearance k 01 was still maintained constant ( min 1 ), in accord with previous studies (13, 24). Comparison Between Model Estimates and Direct-Measurement Data For each set of data, the individualized reconstructed time course CPS(t) was compared with BCS(t) directly measured from the hepatic catheterization experiments. This comparison was also performed for the total amount of insulin secretion in the 180-min interval. It must be noticed that BCS(t) is expressed in picomoles per minute, whereas CPS(t) is expressed per unit volume. Thus, to compare the two variables with the same units, it was necessary to divide BCS(t) by the individual insulin distribution volume, calculated on the assumption of a distribution volume per unit of body weight of 78 ml/kg (6) ( , , and l for control, obese, and diabetic subjects, respectively). The measured clearances of insulin and C-peptide, calculated according to Eqs. 7 and 8, were compared with the corresponding model parameters n and k 01, respectively. For this purpose, measured clearances were divided by the distribution volume to obtain fractional clearances (min 1 ). To compare measured and model estimated hepatic insulin fractional extraction, the time average of the measured extraction over the 180-min interval was computed.
4 INSULIN AND C-PEPTIDE SECRETION AND KINETICS E969 Fig. 3. Pancreatic secretion rate of insulin and C-peptide (means SE) during OGTT calculated from measured data. F, Control; E, obese; Œ, diabetic subjects. Fig. 2. Measured concentrations (means SE) in the artery of glucose (A), insulin (B), and C-peptide (C) during the oral glucose tolerance test (OGTT). F, Control; E, obese; Œ, diabetic subjects. Calculations and Statistical Analysis All numerical calculations and parameter estimations were performed using MATLAB (The Mathworks), and numerical simulations were performed using the PANSYM software (22). Results are presented as means SE unless otherwise designated. Nonparametric tests were used for statistical comparisons. In particular, comparisons between different groups were performed by the Mann-Whitney U-test, whereas those between model and experimental results were done by the Wilcoxon signed-rank test. The relationship between model and experimental results was also investigated by linear regression analysis. Regression was also used to investigate the relationship between measured hepatic blood flow and hepatic insulin fractional extraction and hepatic insulin clearance. RESULTS Direct Measurements from Hepatic Catheterization OGTT. The time courses of the concentrations in the hepatic artery of the measured compounds after the administration of the oral glucose load are presented in Fig. 2. The patterns of C-peptide and insulin were qualitatively similar, with the typical hyperinsulinemia in obese and hypoinsulinemia in diabetic subjects. Glucose levels were not different between control and obese subjects, whereas diabetic subjects showed a marked hyperglycemia. Similar patterns, but higher values, were observed for the concentrations in the hepatic vein (not shown). The basal values and the AUCs for C-peptide, insulin, and glucose are reported in Table 1. Insulin and C-peptide secretion. -Cell C-peptide and insulin secretion time course BCS(t) is shown in Fig. 3. The total amount of hormone released by the -cell (in 180 min) was higher in obese than in control and diabetic subjects (Table 1). When the total amounts of Table 1. Measured values and calculated parameters from the hepatic catheterization experiments P Values Unit C O D C vs. O C vs. D O vs. D Hepatic blood flow ml/min 1, , , Basal glucose mmol/l Basal insulin pmol/l Basal C-peptide pmol/l OGTT AUC glucose mol l 1 min OGTT AUC insulin nmol l 1 min OGTT AUC C-peptide nmol l 1 min Total amount of insulin secretion nmol Hepatic insulin extraction % Hepatic insulin clearance l/min Systemic insulin clearance l/min Systemic C-peptide clearance l/min Values are means SE. C, control; O, obese; D, diabetic; OGTT, oral glucose tolerance test; AUC, area under the curve.
5 E970 INSULIN AND C-PEPTIDE SECRETION AND KINETICS Table 2. Statistical comparison between model-estimated parameters and the corresponding parameters obtained from the hepatic catheterization experiments P Values Unit C O D C vs. O C vs. D O vs. D Total amount of insulin secretion unit volume nmol/l Model estimates Experimental data Comparison between model and experiment: P 0.92 P 0.60 P 0.35 Hepatic insulin extraction % Model estimates Experimental data Comparison between model and experiment: P 0.12 P 0.12 P 0.60 Systemic insulin fractional clearance min 1 Model estimates Experimental data Comparison between model and experiment: P 0.92 P 0.75 P 0.35 Systemic C-peptide fractional clearance min 1 Model estimates Experimental data Comparison between model and experiment: P 0.92 P 0.35 P 0.46 Total amount of insulin secretion and clearances from the experiments have been normalized to the distribution volume. Fig. 4. Regression plot of measured time samples of hepatic blood flow vs. those of hepatic insulin fractional extraction for the obese subjects. hormone released in control and diabetic subjects were compared, no difference was found; however, when only the first 60 min were considered, the two secretory patterns were different (41 11 nmol in control and 17 4 in diabetic subjects, P 0.037), confirming the lack of early-phase release typical of diabetic patients. Moreover, when the total amount of insulin secretion was normalized to the distribution volume of each subject, it was found to be lower in diabetic than in control subjects in the 180-min interval also (Table 2). The -cell sensitivity index was nmol/ (mmol l 1 min 1 ) in control, in obese and in diabetic subjects, different in each class with respect to the others (P 0.03). Clearances and hepatic extraction. Time average over the 180-min interval of the hepatic insulin fractional extraction (expressed as percentage of the insulin amount entering the liver) was found to be higher in diabetic than in control but not in obese subjects (Table 1), whereas hepatic insulin clearance was not different in the three groups (Table 1). A significant negative linear relationship (regression coefficient , P , r ) was found between hepatic blood flow and hepatic insulin fractional extraction in obese subjects (Fig. 4). Conversely, no significant relationship between the two variables was found in control (P 0.07) and diabetic subjects (P 0.2). Regression between hepatic blood flow and hepatic insulin clearance was not significant in any class (P 0.9 in control, P 0.16 in obese, and P 0.10 in diabetic subjects). The time average over the 180-min interval of the hepatic blood flow is reported in Table 1. Systemic C-peptide and insulin clearances are reported in Table 1. That of C-peptide was higher in obese than in control subjects, but when it was normalized to the distribution volume to obtain the C-peptide fractional clearance, no difference was observed (Table 2). Insulin clearance was not different in the three groups (Table 1). Fractional insulin clearance of obese subjects was lower than in diabetic but not lower than in control subjects (Table 2). Model-Derived Estimates Model fit of C-peptide and insulin data. Figure 5 shows the model fit for the mean C-peptide and insulin concentration data along with the pattern of residuals. In Table 2, the model-estimated parameters are shown for the three groups. Their precision, assessed by the coefficient of variation, i.e., the ratio of the diagonal element of the covariance matrix to the parameter value, was 47% for F, 35% for n, and 3% for CPS(t). Comparison between model-derived and measured variables. Model-reconstructed CPS(t) was compared with the measured insulin secretion BCS(t) normalized to the distribution volume, and the two patterns were similar in every group (Fig. 6). A good correlation was found between measured and model-estimated mean values at any sampling time points (Fig. 7). Similarly, the normalized total amount of insulin secretion (Table 2) was not different from the corresponding measured quantity (Table 2), and the two were highly correlated (Fig. 8, A). Moreover, according to experimental results, model estimates confirmed the difference in the
6 INSULIN AND C-PEPTIDE SECRETION AND KINETICS E971 normalized total amount of insulin secretion in each class with respect to the others (Table 2). Although the correlation among individual values was not excellent (Fig. 8, B), estimated hepatic insulin fractional extraction was not different from that directly measured (Table 2). Despite the fact that individual values were found to be poorly correlated (Fig. 8, C), estimated insulin fractional clearance was not different from the corresponding measured quantity (Table 2). The value assumed for C-peptide fractional clearance was not different from the corresponding measured values (Table 2). DISCUSSION The present study addresses two main issues: the analysis of experimental data from hepatic catheterization and the validation of a mathematical model of insulin secretion and kinetics. By use of hepatic catheterization, direct measurements were obtained for secretion and kinetics of insulin and C-peptide during an OGTT. This test was chosen because it is simple to perform, its use is widespread, and it is considered a physiological dynamic test. This study confirms insulin hypersecretion in obese compared with lean subjects and impairment of insulin secretion in type 2 diabetic patients. These patients also showed increased arterial glucose levels, as expected, mirrored by their decreased -cell sensitivity to glucose. Fig. 5. Insulin (left) and C-peptide (right) concentration values for the control (A), obese (B) and diabetic (C) group directly measured (F; means SE), and reconstructed by the model (solid curve, representing the average model fit of the data). For every fit, the time course of the residuals is shown (insets; means SE). In many studies, it is assumed that the level of insulinemia depends almost entirely on insulin secretion; however, the role of metabolic clearance should also be taken into account. Hepatic catheterization allowed the direct assessment of hepatic extraction and clearance as well as systemic insulin and C-peptide clearances. Because no difference in absolute or fractional insulin clearance was observed in obese and diabetic compared with control subjects, the hyperinsulinemia typical of obesity and the hypoinsulinemia of diabetes seem to be due only to enhanced or reduced secretion, respectively. A minor role, however, is played in diabetic subjects by hepatic extraction, which was found to be slightly higher in this group, contributing, therefore, to further lowering of systemic insulin. C-peptide clearance was higher in obese subjects, probably due to the larger distribution volume in these subjects. In fact, when C-peptide clearance was normalized to the distribution volume, no difference was observed between the three groups. The second aim of this study was the validation of a mathematical model (23) developed to assess prehepatic C-peptide and insulin secretion and hepatic insulin extraction from systemic measurements during an OGTT. Mathematical modeling plays a key role in the estimation of these metabolic parameters that can hardly be measured directly in human subjects, and certainly not in the clinical routine. For that validation, we compared model estimates of insulin secretion
7 E972 INSULIN AND C-PEPTIDE SECRETION AND KINETICS Fig. 6. Normalized pancreatic secretion rate directly measured (F) in the 3 groups (means SE) compared with the same variable obtained by the model [mean (solid curves) and confidence interval at 95% (dashed curves)], for control (A), obese (B), and diabetic (C) subjects, respectively. time courses and parameters with the corresponding variables directly measured with the hepatic catheterization experiment. As shown in Fig. 6, the average time courses of prehepatic secretion that the model reconstructs were similar to those measured directly, despite measured patterns that were quite variable. From a quantitative point of view, the values of the total amount of released insulin were very similar. To compare the prehepatic secretion from the experiments with the prehepatic secretion estimated by the model, it was necessary to normalize the former to the insulin distribution volume to have both variables in the same units. The same procedure was used to compare clearances. The choice of the insulin distribution volume is therefore a critical aspect, but there is still a lack of knowledge about this physiological variable. Because we were unable to measure the distribution volume from our experiments, we had to choose a value reported in the Fig. 7. Plot of mean time samples of normalized pancreatic secretion of insulin and C-peptide from measured data vs. model estimates (F, control; E, obese; Œ, diabetic subjects). Unit slope line (dashed line) and regression line at zero intercept (solid line) are reported (regression coefficient , P , r ). literature (6), obtained from a noncompartmental analysis of pork insulin bolus during a hypoglycemic clamp. The same distribution volume per unit of body weight was used for control, obese, and diabetic subjects. In fact, to the best of our knowledge, only a few studies have been carried out on possible differences in the Fig. 8. Plot of individual values from measured data vs. model estimates for total amount of insulin secretion (A), hepatic insulin extraction (B), and systemic insulin fractional clearance (C) (F, control; E, obese; Œ, diabetic subjects). Unit slope line (dashed line) and regression line at zero intercept (solid line) are reported (regression coefficient , P , r for secretion, , P , r for extraction, , P , r for clearance, respectively).
8 INSULIN AND C-PEPTIDE SECRETION AND KINETICS E973 insulin distribution volume between different classes of subjects. McGuire et al. (14) found a reduced distribution volume in obese with respect to nonobese subjects ( 30%), and in diabetic with respect to nondiabetic subjects (10 20%). However, the absolute value of the estimate varied by as much as a factor of five, depending on the insulin kinetics model used. Opposite results with regard to diabetic compared with nondiabetic subjects (increase of 40%) were found by Navalesi et al. (15). Thus, because of the evident uncertainty in the estimation of this parameter, we neglected possible variations that could occur between subjects with different characteristics and pathologies. It is worth noting that we used the distribution volume only to allow comparison between results expressed in different units. If different values were selected, the comparisons would be affected in terms of absolute values, but not in terms of correlation between experimental and model based findings. Hepatic insulin extraction in each class of subjects as estimated by the model was in accord with the measured mean value, although individual correlation was not excellent. It is worth noting, however, that hepatic insulin extraction from experimental data is likely to be less accurate than the measurement of insulin secretion, due to error propagation in its calculation (see Eqs. 2 5). This is reflected in uncertainty in the comparison between model-based and experimental findings. Another possible reason for the low correlation may be the small number of subjects. However, because the experimental protocol is complex and invasive in humans, it has been possible to carry out this investigation only in a few subjects per class. One of the assumptions of the model is a constant hepatic extraction for each subject. However, experimental data revealed a significant relationship between hepatic blood flow and hepatic extraction in obese subjects, in accord with conclusions from a previous study (24). Thus these results support the hypothesis that hepatic extraction is not constant in these subjects and that it depends on hepatic blood flow, which is not constant during an OGTT. Consequently, at least for obese subjects, the model estimation of a constant parameter has to be considered an approximation. On the other hand, it is not possible to further increase the number of parameters estimated by the model and maintain an acceptable accuracy. Moreover, both hepatic blood flow and hepatic extraction from experimental data do not actually exhibit marked changes with respect to their time average (standard error with respect to time average equal to 1.8, 2.4, and 2.8% in control, obese, and diabetic subjects, respectively, for hepatic blood flow and 7.5, 4.1, and 4.0% for hepatic extraction). Thus the assumption of a constant model parameter for representing hepatic extraction can be considered a reasonable choice, although it may partially contribute to the observed differences between model estimates and experimental results. The model presented in this study also allows estimation of systemic insulin clearance; that in the original version (23) was fixed to values obtained from other studies (10 12) or from the literature (18, 21). The data set of the present study, in fact, allowed estimation of at least one more parameter, maintaining an acceptable accuracy in the estimates. We chose to estimate insulin clearance, because it has been reported to exhibit changes in different conditions and to be quite variable, even in normal subjects (6). On the contrary, C-peptide clearance was left at a fixed value, as in the original version, because several studies (16 18, 25) have reported a virtually unchanged C-peptide clearance in many different pathophysiological conditions. Those authors experience with the intravenous glucose test demonstrated that only in subjects with a clear impairment in renal function was C-peptide clearance significantly reduced (9). Similarly to the hepatic extraction, the model estimated well in each class the mean values of the measured systemic insulin clearance, but individual values were poorly correlated. This could be due to the limits of the description of insulin kinetics of the model used, although in this case also problems of error propagation in the computation of this variable from experimental data (see Eq. 8), as well as the modest number of subjects, could have played a significant role. A larger number of subjects would help to clarify the reason for the observed poor correlation. C-peptide clearances from experimental results confirmed the adequacy of the choice of a fixed parameter, being similar in the three groups and not different from the value assumed in the model. In conclusion, in the experimental part of this study, we provided direct confirmation of altered insulin secretion in obese and diabetic subjects. Information was obtained on clearance, which is less often investigated. Finally, it was shown that a previously introduced model of insulin secretion and kinetics during an OGTT in humans provides accurate estimates of prehepatic insulin secretion, as well as some information on hepatic insulin extraction and clearance, in a single subject. Thus, because the direct measure of these variables is not feasible in the clinical routine, the presented model-based approach is a useful tool for the assessment of insulin secretion and kinetics during an OGTT in different pathophysiological conditions, although changes in the model formulation are probably necessary to improve the estimation of insulin clearance and hepatic extraction. We are grateful to Dr. A. Mari of the Institute of Systems Science and Biomedical Engineering (LADSEB) for helpful comments and advice. This study was supported in part by the Progetto Strategico Metodi e Modelli Matematici nello Studio dei Fenomeni Biologici [Decreto Consiglio Nazionale delle Ricerche (CNR) /10/98]. Hepatic catheterization experiments were performed in San Diego (Veterans Affairs Hospital, University of California, San Diego) during a visit of J. Nolan and B. Ludvik, with the support of Dr. J. Olefsky. During the early stage of this study, G. Pacini and K. Thomaseth were supported in part by the CNR with a grant Progetto Bilaterale assigned to K. Thomaseth for cooperative projects between LADSEB and the Third Medical Clinic of the University of Vienna.
9 E974 INSULIN AND C-PEPTIDE SECRETION AND KINETICS REFERENCES 1. Bergman RN, Phillips LS, and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and -cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: , Cobelli C and Pacini G. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes 37: , De Boor C. A Practical Guide to Splines. New York: Springer Verlag, Desbuquois B and Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33: , Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, and Rubenstein AH. Characterization of seven C-peptide antisera. Diabetes 27, Suppl 1: , Ferrannini E and Cobelli C. The kinetics of insulin in man. Diabetes Metab Rev 3: , Fery F and Balasse EO. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes 43: , Gasic S, Kleinbloesem CH, Heinz G, and Waldhäusl W. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-ii and to regional conversion rates of angiotensin-i: a pilot study in humans. J Cardiovasc Pharmacol 17: , Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, and Prager R. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 47: , Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, and Prager R. -Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41: , Kautzky-Willer A, Pacini G, Weissel M, Capek M, Ludvik B, and Prager R. Elevated hepatic insulin extraction in essential hypertension. Hypertension 21: , Kautzky-Willer A, Thomaseth K, Clodi M, Ludvik B, Waldhäusl W, Prager R, and Pacini G. -Cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 45: , Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhäusl W, Pacini G, and Prager R. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46: , McGuire EA, Tobin JD, Berman M, and Andres R. Kinetics of native insulin in diabetic, obese, and aged man. Diabetes 28: , Navalesi R, Pilo A, and Ferrannini E. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125 I-insulin. J Clin Invest 61: , Pacini G. Mathematical models of insulin secretion in physiological and clinical investigations. Comput Methods Programs Biomed 41: , Pacini G and Thomaseth K. -Cell secretion from modeling intravenous and oral glucose tests. In: The Minimal Model Approach and Determinants of Glucose Tolerance, edited by RN Bergman and JC Lovejoy. Baton Rouge: LSU Press, 1997, p Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, and Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77: , Rowell LB, Blackmon JR, and Bruce RA. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43: , Rubenstein AH, Pottenger LA, Mako M, Getz GS, and Steiner DF. The metabolism of proinsulin and insulin by the liver. J Clin Invest 51: , Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, and Andres R. A model of the kinetics of insulin in man. J Clin Invest 53: , Thomaseth K. PANSYM: a tool for mathematical modelling, analysis and control of metabolic and pharmacokinetic systems. Comput Methods Programs Biomed 41: , Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, and Pacini G. Integrated mathematical model to assess -cell activity during the oral glucose test. Am J Physiol Endocrinol Metab 270: E522 E531, Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, and Ludvik B. Amylin release during oral glucose tolerance test. Diabet Med 14: S29 S34, Van Cauter E, Mestrez F, Sturis J, and Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C- peptide clearance. Diabetes 41: , Vølund A, Polonsky KS, and Bergman RN. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes 36: , 1987.
The oral meal or oral glucose tolerance test. Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol Minimal Model Assessment of -Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals Chiara Dalla Man,
More informationEvidence for Decreased Splanchnic Glucose Uptake after Oral Glucose Administration in Non Insulin-dependent Diabetes Mellitus
Evidence for Decreased Splanchnic Glucose Uptake after Oral Glucose Administration in Non Insulin-dependent Diabetes Mellitus Bernhard Ludvik,* John J. Nolan,* Anne Roberts, Joseph Baloga,* Mary Joyce,*
More informationMETABOLISM CLINICAL AND EXPERIMENTAL XX (2011) XXX XXX. available at Metabolism.
METABOLISM CLINICAL AND EXPERIMENTAL XX (211) XXX XXX available at www.sciencedirect.com Metabolism www.metabolismjournal.com Estimation of prehepatic insulin secretion: comparison between standardized
More informationAlternative insulin delivery systems: how demanding should the patient be?
Diabetologia (1997) 4: S97 S11 Springer-Verlag 1997 Alternative insulin delivery systems: how demanding should the patient be? K.S. Polonsky, M. M. Byrne, J. Sturis Department of Medicine, The University
More informationElectronic Supplementary Material to the article entitled Altered pattern of the
Electronic Supplementary Material to the article entitled Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic Integrated
More informationC-Peptide and Insulin Secretion Relationship between Peripheral Concentrations of C-Peptide and Insulin and their Secretion Rates in the Dog
C-Peptide and Insulin Secretion Relationship between Peripheral Concentrations of C-Peptide and Insulin and their Secretion Rates in the Dog K. S. Polonsky, W. Pugh, J. B. Jaspan, D. M. Cohen, T. Karrison,
More informationQuantitative indexes of -cell function during graded up&down glucose infusion from C-peptide minimal models
Am J Physiol Endocrinol Metab 280: E2 E10, 2001. Quantitative indexes of -cell function during graded up&down glucose infusion from C-peptide minimal models GIANNA TOFFOLO, 1 ELENA BREDA, 1 MELISSA K.
More informationUlrike Pielmeier*. Mark L. Rousing* Steen Andreassen*
Preprints of the 19th World Congress The International Federation of Automatic Control Pancreatic secretion, hepatic extraction, and plasma clearance of insulin from steady-state insulin and C-peptide
More informationInsulin Secretion and Hepatic Extraction during Euglycemic Clamp Study: Modelling of Insulin and C-peptide data
Insulin Secretion and Hepatic Extraction during Euglycemic Clamp Study: Modelling of Insulin and C-peptide data Chantaratsamon Dansirikul Mats O Karlsson Division of Pharmacokinetics and Drug Therapy Department
More informationDavid C. Polidori, 1 Richard N. Bergman, 2 Stephanie T. Chung, 3 and Anne E. Sumner 3
1556 Diabetes Volume 65, June 2016 David C. Polidori, 1 Richard N. Bergman, 2 Stephanie T. Chung, 3 and Anne E. Sumner 3 Hepatic and Extrahepatic Insulin Clearance Are Differentially Regulated: Results
More information28 Regulation of Fasting and Post-
28 Regulation of Fasting and Post- Prandial Glucose Metabolism Keywords: Type 2 Diabetes, endogenous glucose production, splanchnic glucose uptake, gluconeo-genesis, glycogenolysis, glucose effectiveness.
More informationA Minimal C-Peptide Sampling Method to Capture Peak and Total Prehepatic Insulin Secretion in Model-Based Experimental Insulin Sensitivity Studies
Journal of Diabetes Science and Technology Volume 3, Issue 4, July 29 Diabetes Technology Society ORIGINAL ARTICLES A Minimal C-Peptide Sampling Method to Capture Peak and Total Prehepatic Insulin Secretion
More informationDiabetologia 9 Springer-Verlag 1984
Diabetologia (1984) 26:203 207 Diabetologia 9 Springer-Verlag 1984 How does glucose regulate the human pancreatic A cell in vivo? C. M. Asplin*, P. M. Hollander** and J. P. Palmer Diabetes Research Center
More informationType 2 diabetes is characterized by a defect in
Validation of Methods for Measurement of Insulin Secretion in Humans In Vi v o Lise L. Kjems, Erik Christiansen, Aage Vølund, Richard N. Bergman, and Sten Madsbad To detect and understand the changes in
More informationDiabetologia 9 Springer-Verlag 1982
Diabetologia (1982) 22:245-249 Diabetologia 9 Springer-Verlag 1982 Twenty-Four Hour Profiles of Plasma C-Peptide in Type 1 (Insulin-Dependent) Diabetic Children G. A. Werther 1 *, R. C. Turner 2, P. A.
More informationDecreased Non Insulin-Dependent Glucose Clearance Contributes to the Rise in Fasting Plasma Glucose in the Nondiabetic Range
Pathophysiology/Complications O R I G I N A L A R T I C L E Decreased Non Insulin-Dependent Glucose Clearance Contributes to the Rise in Fasting Plasma Glucose in the Nondiabetic Range RUCHA JANI, MD MARJORIE
More informationAn integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers
Title: An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers Authors: Hanna E. Silber 1, Nicolas Frey 2 and Mats O. Karlsson 1 Address: 1 Department of
More informationCharacterization of GLP-1 Effects on -Cell Function After Meal Ingestion in Humans
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Characterization of GLP-1 Effects on -Cell Function After Meal Ingestion in Humans BO AHRÉN, MD, PHD 1 JENS J. HOLST, MD, PHD 2 ANDREA
More informationDecreased Non-Insulin Dependent Glucose Clearance Contributes to the Rise in FPG in the Non-Diabetic Range.
Diabetes Care Publish Ahead of Print, published online November 13, 2007 Decreased Non-Insulin Dependent Glucose Clearance Contributes to the Rise in FPG in the Non-Diabetic Range. Rucha Jani, M.D., Marjorie
More informationAnalysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric Modeling: Application to a Population at Risk for Diabetes
Journal of Diabetes Science and Technology Volume 7, Issue 4, July 2013 Diabetes Technology Society ORIGINAL ARTICLE Analysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric
More informationCircadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm
Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm EVE VAN CAUTER, E. TIMOTHY SHAPIRO, HARTMUT TILLIL, AND KENNETH S. POLOKY Department of Medicine, University
More informationAdapting to insulin resistance in obesity: role of insulin secretion and clearance
Diabetologia (218) 61:681 687 https://doi.org/1.17/s125-17-4511- ARTICLE Adapting to insulin resistance in obesity: role of insulin secretion and clearance Sang-Hee Jung 1 & Chan-Hee Jung 2 & Gerald M.
More informationOutline Insulin-Glucose Dynamics a la Deterministic models Biomath Summer School and Workshop 2008 Denmark
Outline Insulin-Glucose Dynamics a la Deterministic models Biomath Summer School and Workshop 2008 Denmark Seema Nanda Tata Institute of Fundamental Research Centre for Applicable Mathematics, Bangalore,
More informationThe hot IVGTT two-compartment minimal model: indexes? of glucose effectiveness and insulin sensitivity
The hot IVGTT two-compartment minimal model: indexes? of glucose effectivene and insulin sensitivity Paolo Vicini, Andrea Caumo and Claudio Cobelli Am J Physiol Endocrinol Metab 273:E1024-E1032, 1997.
More informationPlasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test
Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test Robert Hahn and Thomas Nystrom Linköping University Post Print N.B.: When citing this work, cite the original article. This is
More informationInsulin Control System for Diabetic Patients by Using Adaptive Controller
J. Basic. Appl. Sci. Res., 1(10)1884-1889, 2011 2011, TextRoad Publication ISSN 2090-4304 Journal of Basic and Applied Scientific Research www.textroad.com Insulin Control System for Diabetic Patients
More informationGlucagon secretion in relation to insulin sensitivity in healthy subjects
Diabetologia (2006) 49: 117 122 DOI 10.1007/s00125-005-0056-8 ARTICLE B. Ahrén Glucagon secretion in relation to insulin sensitivity in healthy subjects Received: 4 July 2005 / Accepted: 12 September 2005
More informationBASIC PHARMACOKINETICS
BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter
More informationGamma Variate Analysis of Insulin Kinetics in Type 2 Diabetes
Gamma Variate Analysis of Insulin Kinetics in Type 2 Diabetes Anthony Shannon Faculty of Engineering & IT, University of Technology Sydney, NSW 2007, Australia PO Box 314, Balgowlah, NSW 2093, Australia
More informationMathematical model of standard oral glucose tolerance test for characterization of insulin potentiation in health
Università Politecnica delle Marche Scuola di Dottorato di Ricerca in Scienze dell Ingegneria Curriculum in Elettromagnetismo e Bioingegneria ----------------------------------------------------------------------------------------
More informationInsulin release, insulin sensitivity, and glucose intolerance (early diabetes/pathogenesis)
Proc. Natl. Acad. Sci. USA Vol. 77, No. 12, pp. 7425-7429, December 1980 Medical Sciences nsulin release, insulin sensitivity, and glucose intolerance (early diabetes/pathogenesis) SUAD EFENDt, ALEXANDRE
More informationFeedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity
European Review for Medical and Pharmacological Sciences 1997; 1: 17-171 Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity d. sinagra,
More informationA Proportional-Derivative Endogenous Insulin Secretion model with an Adapted Gauss Newton Approach
A Proportional-Derivative Endogenous Insulin Secretion model with an Adapted Gauss Newton Approach Nor Azlan Othman, Paul D. Docherty, Nor Salwa Damanhuri and J. Geoffrey Chase Department of Mechanical
More informationChapter 4. Acute and 2-Week Exposure to Prednisolone Impair Different Aspects of Beta-Cell Function in Healthy Men
Chapter 4 Acute and 2-Week Exposure to Prednisolone Impair Different Aspects of Beta-Cell Function in Healthy Men D.H. van Raalte, V. Nofrate, M.C. Bunck, T. van Iersel, J. Elassaiss Schaap, U.K Nässander,
More informationThe Regulation of Liver Glucose Production and Uptake
The Regulation of Liver Glucose Production and Uptake Vanderbilt University Medical Center Nashville, TN USA Dale Edgerton, PhD An Organ Systems Approach to Experimental Targeting of the Metabolic Syndrome
More informationDiabetologia 9 Springer-Verlag 1989
Diabetologia (1989) 32:858-863 Diabetologia 9 Springer-Verlag 1989 The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled Type 2 (non-insulin-dependent)
More informationCausal Modeling of the Glucose-Insulin System in Type-I Diabetic Patients J. Fernandez, N. Aguilar, R. Fernandez de Canete, J. C.
Causal Modeling of the Glucose-Insulin System in Type-I Diabetic Patients J. Fernandez, N. Aguilar, R. Fernandez de Canete, J. C. Ramos-Diaz Abstract In this paper, a simulation model of the glucoseinsulin
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationINSULIN IS A key regulator of glucose homeostasis. Insulin
0021-972X/00/$03.00/0 Vol. 85, No. 7 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple,
More informationPHARMACOKINETICS OF DRUG ABSORPTION
Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Applied Biopharmaceutics & Pharmacokinetics > Chapter 7. Pharmacokinetics of Oral Absorption >
More informationPancreatic Insulinoma Presenting. with Episodes of Hypoinsulinemic. Hypoglycemia in Elderly ---- A Case Report
2008 19 432-436 Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report Chieh-Hsiang Lu 1, Shih-Che Hua 1, and Chung-Jung Wu 2,3 1 Division of Endocrinology
More informationControversy has long characterized the questions
Accurate Measurement of Endogenous Insulin Secretion Does Not Require Separate Assessment of C-Peptide Kinetics Richard M. Watanabe and Richard N. Bergman The implication of -cell failure as an early defect
More informationSIMULATIONS OF A MODEL-BASED FUZZY CONTROL SYSTEM FOR GLYCEMIC CONTROL IN DIABETES
Bulletin of the Transilvania University of Braşov Vol. 8 (57) No. 2-2015 Series I: Engineering Sciences SIMULATIONS OF A MODEL-BASED FUZZY CONTROL SYSTEM FOR GLYCEMIC CONTROL IN DIABETES C. BOLDIȘOR 1
More informationIntroduction ORIGINAL RESEARCH. Bilal A. Omar 1, Giovanni Pacini 2 & Bo Ahren 1. Abstract
ORIGINAL RESEARCH Physiological Reports ISSN 2051-817X Impact of glucose dosing regimens on modeling of glucose tolerance and b-cell function by intravenous glucose tolerance test in diet-induced obese
More informationIncreased Levels of Circulating Islet Amyloid Polypeptide in Patients with Chronic Renal Failure Have No Effect on Insulin Secretion
Increased Levels of Circulating Islet Amyloid Polypeptide in Patients with Chronic Renal Failure Have No Effect on Insulin Secretion Bernhard Ludvik,* Martin Clodi, * Alexandra Kautzky-Willer, * Markus
More informationSUPPLEMENTARY DATA. Supplementary Table S1. Clinical characteristics of the study subjects.*
Supplementary Table S1. Clinical characteristics of the study subjects.* T2D ND n (F/M) 66 (21/45) 25 (7/18) Age (years) 61.8 ± 6.9 49.4 ± 7.3 # Body weight (kg) 95 ± 16 105 ± 13 # Body mass index (kg.
More informationBiopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption
Biopharmaceutics Lecture-11 & 12 Pharmacokinetics of oral absorption The systemic drug absorption from the gastrointestinal (GI) tract or from any other extravascular site is dependent on 1. 2. 3. In the
More informationEarly Detection of Insulin Sensitivity and -Cell Function with Simple Tests Indicates Future Derangements in Late Pregnancy
ORIGINAL Endocrine ARTICLE Care Early Detection of Insulin Sensitivity and -Cell Function with Simple Tests Indicates Future Derangements in Late Pregnancy A. Lapolla, M. G. Dalfrà, G. Mello, E. Parretti,
More informationmu/m2 per min and in 10 Type II diabetic subjects using
Influence of Hyperglycemia on Insulin's In Vivo Effects in Type 11 Diabetes R. R. Revers, R. Fink, J. Griffin, J. M. Olefsky, and. G. Kolterman Division ofendocrinology and Metabolism, University of Colorado
More informationImportance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies
European Journal of Endocrinology (2004) 150 97 104 ISSN 0804-4643 REVIEW Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical
More informationMODELING GLUCOSE-INSULIN METABOLIC SYSTEM AND INSULIN SECRETORY ULTRADIAN OSCILLATIONS WITH EXPLICIT TIME DELAYS. Yang Kuang
MODELING GLUCOSE-INSULIN METABOLIC SYSTEM AND INSULIN SECRETORY ULTRADIAN OSCILLATIONS WITH EXPLICIT TIME DELAYS Yang Kuang (joint work with Jiaxu Li and Clinton C. Mason) Department of Mathematics and
More informationOutline. Model Development GLUCOSIM. Conventional Feedback and Model-Based Control of Blood Glucose Level in Type-I Diabetes Mellitus
Conventional Feedback and Model-Based Control of Blood Glucose Level in Type-I Diabetes Mellitus Barış Ağar, Gülnur Birol*, Ali Çınar Department of Chemical and Environmental Engineering Illinois Institute
More informationThe second meal phenomenon in type 2 diabetes
Diabetes Care Publish Ahead of Print, published online April 14, 2009 Second meal phenomenon and diabetes The second meal phenomenon in type 2 diabetes Ana Jovanovic MD, Jean Gerrard SRN, Roy Taylor MD
More informationBasic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations
Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.
More informationDetermination of bioavailability
Pharmaceutics 2 Bioavailability Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg
More informationPHA5128 Dose Optimization II Case Study I Spring 2013
Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated
More informationGeneral Principles of Pharmacology and Toxicology
General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University
More informationby Springer-Verlag 1977
Diabetologia 13, 263-268 (1977) Diabetologia @ by Springer-Verlag 1977 B-cell Function and Blood Glucose Control in Insulin Dependent Diabetics within the First Month of Insulin Treatment O.K. Faber and
More informationDiabetologia 9 by Springer-Verlag 1978
Diabetologia 15, 159-164 (1978) Diabetologia 9 by Springer-Verlag 1978 Characterisation of the Effect of Intravenous Infusion of Glucose and Tolbutamide on the Insulin Delivery Rate in Man T. Asano, H.
More informationA Mathematical Model of the Human Metabolic System and Metabolic Flexibility
Bull Math Biol manuscript No. (will be inserted by the editor) A Mathematical Model of the Human Metabolic System and Metabolic Flexibility T. Pearson J.A.D. Wattis J.R. King I.A. MacDonald D.J. Mazzatti
More informationActive Insulin Infusion Using Fuzzy-Based Closed-loop Control
Active Insulin Infusion Using Fuzzy-Based Closed-loop Control Sh. Yasini, M. B. Naghibi-Sistani, A. Karimpour Department of Electrical Engineering, Ferdowsi University of Mashhad, Mashhad, Iran E-mail:
More informationDelayed Response of Amylin Levels after an Oral Glucose Challenge in Children with Prader-Willi Syndrome
Original Article DOI 1.3349/ymj.211.52.2.257 pissn: 513-5796, eissn: 1976-2437 Yonsei Med J 52(2):257-262, 211 Delayed Response of Amylin Levels after an Oral Glucose Challenge in Children with Prader-Willi
More information1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?
Page 1 PHAR 750: Biopharmaceutics/Pharmacokinetics October 23, 2009 - Form 1 Name: Total 100 points Please choose the BEST answer of those provided. For numerical answers, choose none of the above if your
More informationUnderstand the physiological determinants of extent and rate of absorption
Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption
More informationabnormally high compared to those encountered when animals are fed by University of Iowa, Iowa City, Iowa, U.S.A.
J. Phy8iol. (1965), 181, pp. 59-67 59 With 5 text-ftgure8 Printed in Great Britain THE ANALYSIS OF GLUCOSE MEASUREMENTS BY COMPUTER SIMULATION* BY R. G. JANES "D J. 0. OSBURN From the Departments of Anatomy
More informationAchieving Open-loop Insulin Delivery using ITM Designed for T1DM Patients
I. J. Computer Network and Information Security, 2012, 1, 52-58 Published Online February 2012 in MECS (http://www.mecs-press.org/) DOI: 10.5815/ijcnis.2012.01.07 Achieving Open-loop Insulin Delivery using
More informationEvaluation of a glomerular filtration term in the DISST model to capture the glucose pharmacodynamics of an insulin resistant cohort
Evaluation of a glomerular filtration term in the DISST model to capture the glucose pharmacodynamics of an insulin resistant cohort Paul D Docherty J Geoffrey Chase Thomas F Lotz Jeremy D Krebs Study
More informationINTERNATIONAL JOURNAL OF PURE AND APPLIED RESEARCH IN ENGINEERING AND TECHNOLOGY
INTERNATIONAL JOURNAL OF PURE AND APPLIED RESEARCH IN ENGINEERING AND TECHNOLOGY A PATH FOR HORIZING YOUR INNOVATIVE WORK A SLIDING MODE CONTROL ALGORITHM FOR ARTIFICIAL PANCREAS NIRLIPTA RANJAN MOHANTY
More informationAnalysis of glucose-insulin-glucagon interaction models.
C.J. in t Veld Analysis of glucose-insulin-glucagon interaction models. Bachelor thesis August 1, 2017 Thesis supervisor: dr. V. Rottschäfer Leiden University Mathematical Institute Contents 1 Introduction
More informationand Hepatic Glucose Output in Normal and Obese Subjects
In Vivo Kinetics of Insulin Action on Peripheral Glucose Disposal and Hepatic Glucose Output in Normal and Obese Subjects Rudolf Prager, Penny Wallace, and Jerrold M. Olefsky Department ofmedicine, University
More informationCOMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010
COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010 Office of Clinical Research Training and Medical Education National
More informationTutorial ADAPT Case study 1. Data sampling / error model. Yared Paalvast Yvonne Rozendaal
Tutorial ADAPT 13.15 17.00 Yared Paalvast (t.paalvast@umcg.nl) Yvonne Rozendaal (y.j.w.rozendaal@tue.nl) Case study 1. Data sampling / error model 1.1 Visualize raw data (dataset1a.mat) time data: t concentration
More informationA Diabetes minimal model for Oral Glucose Tolerance Tests
arxiv:1601.04753v1 [stat.ap] 18 Jan 2016 A Diabetes minimal model for Oral Glucose Tolerance Tests J. Andrés Christen a, Marcos Capistrán a, Adriana Monroy b, Silvestre Alavez c, Silvia Quintana Vargas
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More information7/31/2009. G.Y. Prince Used Cars 10 am Los Angelos, CA Mullholland Drive..later that day. Would you buy a car without taking it for a spin first?
7/31/29 My Anna will love it! Who needs a test drive? Or a Warranty? It looked great in the lot! Do mean to say that you never actually test drove the car? G.Y. Prince Used Cars 1 am Los Angelos, CA Mullholland
More informationGlucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine
Diabetologia (1998) 41: 772±777 Ó Springer-Verlag 1998 Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine H. Larsson,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationDiabetologia 9 by Springer-Verlag 1978
Diabetologia 14, 249-253 (1978) Diabetologia 9 by Springer-Verlag 1978 Hepatic Insulin Responsiveness in Patients with ndogenous Hypertriglyceridaemia R.M. Bernstein, B.M. Davis, J.M. Olefsky, and G.M.
More informationAdeterioration in -cell function is an independent
Relationships Among Age, Proinsulin Conversion, and -Cell Function in Nondiabetic Humans Andreas Fritsche, Alexander Madaus, Norbert Stefan, Otto Tschritter, Elke Maerker, Anna Teigeler, Hans Häring, and
More informationChanges in net hepatic flux of nutrients by deacetylation of p-aminohippuric acid in dairy cows.
Changes in net hepatic flux of nutrients by of p-aminohippuric acid in dairy cows. Rodríguez-López, J.M., Cantalapiedra-Hijar, G., Durand, D., Thomas, A., and Ortigues-Marty, I. INRA, UR 1213, Unité Mixte
More informationSkeletal muscle metabolism was studied by measuring arterio-venous concentration differences
Supplemental Data Dual stable-isotope experiment Skeletal muscle metabolism was studied by measuring arterio-venous concentration differences across the forearm, adjusted for forearm blood flow (FBF) (1).
More informationOne-Compartment Open Model: Intravenous Bolus Administration:
One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.
More informationGlucose Concentration Simulation for Closed-Loop Treatment in Type 1 Diabetes
American Society for Engineering Education (ASEE), Northeast Section Annual Conference, April 27-28, 208 Glucose Concentration Simulation for Closed-Loop Treatment in Type Diabetes Marilyn Urrea, Nora
More information54 IEEE REVIEWS IN BIOMEDICAL ENGINEERING, VOL. 2, 2009
54 IEEE REVIEWS IN BIOMEDICAL ENGINEERING, VOL. 2, 2009 Diabetes: Models, Signals, and Control Claudio Cobelli, Chiara Dalla Man, Giovanni Sparacino, Lalo Magni, Giuseppe De Nicolao, and Boris P. Kovatchev
More informationStability Analysis of Sorensen's Model for Controllability and Observability
Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences 54 (2): 133 145 (2017) Copyright Pakistan Academy of Sciences ISSN: 2518-4261 (print), ISSN 2518-427X (online) Stability
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationInsulin Secretion and Sensitivity during Oral Glucose Tolerance Test in Korean Lean Elderly Women
J Korean Med Sci 2001; 16: 592-7 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Insulin Secretion and Sensitivity during Oral Glucose Tolerance Test in Korean Lean Elderly Women Impaired
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More information5g vs. control, contrast. 10g vs. control, contrast. -3.6e-15 ± 4.3
Supplementary Materials: A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants:
More informationThe Mediterranean Diet: HOW and WHY It Works So Well for T2DM
The Mediterranean Diet: HOW and WHY It Works So Well for T2DM Susan L. Barlow, RD, CDE. Objectives 1. Discuss the effects of meal size on GLP-1 concentrations. 2. Compare and contrast the specific effects
More informationHypoinsulinemia is strongly associated with coronary artery calcification (CAC) assessed by multislice computed tomography
Hypoinsulinemia is strongly associated with coronary artery calcification (CAC) assessed by multislice computed tomography Yohei Oda 1, Muhei Tanaka 2, Michiaki Fukui 2, Sei Tsunoda 1, Satoshi Akabame
More informationb-cells are richly endowed with insulin receptors and Their Role in Human b-cell Dysfunction
ORIGINAL ARTICLE Influence of Hyperinsulinemia and Insulin Resistance on In Vivo b-cell Function Their Role in Human b-cell Dysfunction Andrea Mari, 1 Andrea Tura, 1 Andrea Natali, 2 Christian Anderwald,
More informationGlucose-Insulin Pharmacodynamic Surface Modeling Comparison
Glucose-Insulin Pharmacodynamic Surface Modeling Comparison J. Geoffrey Chase*, Steen Andreassen.**, Ulrike Pielmeier**, Christopher E. Hann * *Mechanical Eng, Centre for Bio-Engineering, University of
More informationQuantitation of Cerebral Glucose Utilization using the Arterial Input Function or the Standardized Uptake Value (SUV)
Quantitation of Cerebral Glucose Utilization using the Arterial Input Function or the Standardized Uptake Value (SUV) Brian R. Moyer BRMoyer & Associates, LLC, Amherst, NH 03031 http://www.brmassocllc-org.com/
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationName: UFID: PHA Exam 2. Spring 2013
PHA 5128 Exam 2 Spring 2013 1 Carbamazepine (5 points) 2 Theophylline (10 points) 3 Gentamicin (10 points) 4 Drug-drug interaction (5 points) 5 Lidocaine (5 points) 6 Cyclosporine (5 points) 7 Phenobarbital
More informationMercodia Porcine C-peptide ELISA
Mercodia Porcine C-peptide ELISA Directions for Use 10-1256-01 REAGENTS FOR 96 DETERMINATIONS Manufactured by Mercodia AB, Sylveniusgatan 8A, SE-754 50 Uppsala, Sweden EXPLANATION OF SYMBOLS USED ON LABELS
More informationBlood glucose concentrations in healthy humans
ORIGINAL ARTICLE Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test Marzieh Salehi, 1 Benedict Aulinger, 1 and David A. D Alessio 1,2 The incretin effect,
More informationAdvantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test
RESEARCH Open Access Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test Simona Panunzi 1*, Andrea De Gaetano 1, Geltrude Mingrone
More informationTitle: Assessment of the post-exercise glycemic response to food: considering prior
Title: Assessment of the post-exercise glycemic response to food: considering prior nutritional status. Authors: Javier T. Gonzalez BSc. MRes., and Emma J. Stevenson BSc. Phd. Brain, Performance and Nutrition
More information